Skip to content
Obsidio
Menu
Technology
Applications
About Us
Press
Publications
Contact
Press
Obsidio, Inc. is selected as a 2020 Rosenman Innovator!
Obsidio announces the formation of clinical advisory board
Obsidio is selected to participate in the TMCx09 Medical Device Accelerator Program
Obsidio Raises Seed Round Led by Good Growth Capital to Develop Universal Gel Embolic Material
Previous Page
1
2